Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat

[1]  C. Waters,et al.  Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis , 1994, Neuroscience.

[2]  I. Mitchell,et al.  Death of neurons in the neonatal rodent and primate globus pallidus occurs by a mechanism of apoptosis , 1994, Neuroscience.

[3]  E. Preston,et al.  Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain , 1993, Neuroscience Letters.

[4]  B. Barres,et al.  Programmed cell death and the control of cell survival: lessons from the nervous system. , 1993, Science.

[5]  Y. Ben‐Ari,et al.  Glutamate‐Induced Neuronal Death Is Not a Programmed Cell Death in Cerebellar Culture , 1993, Journal of neurochemistry.

[6]  M. Beal,et al.  NMDA antagonists partially protect against MPTP induced neurotoxicity in mice , 1993, Neuroreport.

[7]  D. Choi.  Excitotoxic cell death. , 1992, Journal of neurobiology.

[8]  In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-d-aspartate antagonists , 1992, Brain Research.

[9]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[10]  E. Ignatowicz,et al.  Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis. , 1991, Neuroreport.

[11]  T. Klockgether,et al.  The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys , 1991, Annals of neurology.

[12]  T. Yoshimoto,et al.  Glutamate triggers internucleosomal DNA cleavage in neuronal cells. , 1991, Biochemical and biophysical research communications.

[13]  R. Oppenheim.  Cell death during development of the nervous system. , 1991, Annual review of neuroscience.

[14]  J. Brotchie,et al.  Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate , 1991, Movement disorders : official journal of the Movement Disorder Society.

[15]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[16]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[17]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[18]  A. D. Smith,et al.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.

[19]  R. G. Robertson,et al.  Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1989, Neuroscience.

[20]  W. Nicklas,et al.  Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. , 1989, Science.

[21]  S. P. Hunt,et al.  Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea , 1988, Neuroscience.

[22]  A. Thomson,et al.  An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? , 1985, Nature.

[23]  A. Wyllie,et al.  Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis , 1984, The Journal of pathology.

[24]  Y. Agid,et al.  Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains , 1982, Brain Research.

[25]  N. Andén.  Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system. , 1967, European journal of pharmacology.

[26]  Å. Bertler.  Effect of Reserpine on the Storage of Catechol Amines in Brain and Other Tissues , 1961 .

[27]  A. Carlsson,et al.  3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists , 1957, Nature.

[28]  J. Greenfield,et al.  THE BRAIN-STEM LESIONS IN PARKINSONISM , 1953, Journal of neurology, neurosurgery, and psychiatry.